We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Clinical Trial Follow-up Study of the Genesis II Posterior Stabilized Total Knee Replacement

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00351793
First Posted: July 13, 2006
Last Update Posted: February 1, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Nova Scotia Health Authority
Information provided by (Responsible Party):
Ross Leighton, Nova Scotia Health Authority
July 12, 2006
July 13, 2006
February 1, 2017
January 2003
December 2018   (Final data collection date for primary outcome measure)
Effectiveness and Safety [ Time Frame: 5 years ]
Will evaluate effectiveness and safety during a 5 year period via analysis of the Knee Society Score, revision status, and radiographic evaluation
Not Provided
Complete list of historical versions of study NCT00351793 on ClinicalTrials.gov Archive Site
  • Knee Society Clinical Rating [ Time Frame: Pre-op, 6 months, 1 year, 2 years, 5 years ]
  • Western Ontario and MacMaster Universities Osteoarthritis Index (WOMAC) [ Time Frame: Pre-op, 6 months, 1 year, 2 years, 5 years ]
Not Provided
Not Provided
Not Provided
 
A Clinical Trial Follow-up Study of the Genesis II Posterior Stabilized Total Knee Replacement
A Clinical Trial Follow-up Study of the Genesis II Posterior Stabilized Total Knee Replacement
The purpose of this study is to look at the outcomes of the GENESIS II Posterior Stabilized Total Knee Replacement.
Not Provided
Observational
Observational Model: Case-Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Total knee replacement candidates
Osteoarthritis
Device: Knee Implant
Total knee replacement with Genesis II posterior stabilized knee
  • Combined Deformity <30 degrees
    Intervention: Device: Knee Implant
  • Combined Deformity >30 degrees
    Intervention: Device: Knee Implant
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
186
December 2018
December 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • A combined deformity of <30 degrees = group 1
  • A combined deformity of >30 degrees = group 2
  • Patient is willing to consent to participate in the study
  • Patient is available for follow-up through at least 2 years but preferably 5 years
  • Patient has met acceptable preoperative medical clearance and is free of or treated for medical conditions that would pose excessive operative risk
  • Patients who are fluent in English and are able to understand their role in a clinical trial

Exclusion Criteria:

  • Active, local infection or systemic infection
  • Fibromyalgia patients
  • Patients whom, as judged by the surgeon, are not capable of understanding the informed consent or the requirements of the protocol and or are reasonably unlikely to be compliant with the prescribed routine and the follow-up evaluation schedule
Sexes Eligible for Study: All
Child, Adult, Senior
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
 
NCT00351793
CDHA-RL-004
No
Not Provided
Not Provided
Ross Leighton, Nova Scotia Health Authority
Ross Leighton
Nova Scotia Health Authority
Principal Investigator: Ross K Leighton, MD, FRCS(C) Capital Health, Canada
Nova Scotia Health Authority
January 2017